Marvin Langston

Dr. Marvin Langston applies his expertise to solve challenges in the field of prostate cancer and urology, with a particular focus on the discovery and application of biomarkers. As an Assistant Professor of Epidemiology and Population Health at Stanford University, he is dedicated to advancing the understanding of both benign and malignant prostate conditions. Since joining the faculty in 2022, Dr. Langston has been at the forefront of research that seeks to harmonize molecular and clinical aspects of urological conditions, aiming to facilitate biomarker discovery and etiological investigations. Dr. Langston earned his PhD in Epidemiology from the University of Arizona, where he developed a strong foundation in the study of disease patterns and risk factors. His academic journey has been marked by a commitment to integrating epidemiological methods with clinical insights, a combination that is crucial for advancing personalized medicine in urology. His work is characterized by a multidisciplinary approach, bringing together elements of molecular biology, clinical practice, and population health. In his current role, Dr. Langston is involved in several collaborative projects that aim to identify novel biomarkers for prostate cancer, which could lead to improved diagnostic and prognostic tools. His research is not only pivotal in understanding the biological underpinnings of prostate conditions but also in translating these findings into practical applications that can enhance patient care. By focusing on the intersection of molecular and clinical data, Dr. Langston's work contributes to the broader goal of improving outcomes for individuals affected by urological diseases. Beyond his research, Dr. Langston is committed to mentoring the next generation of epidemiologists and healthcare professionals. He actively engages with students and colleagues, fostering an environment of inquiry and innovation. His dedication to education and research excellence makes him a valuable asset to the Stanford community and the field of epidemiology at large.